{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:44:09Z","timestamp":1791873849576,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2938,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.virol.2005.04.028","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T11:46:32Z","timestamp":1118403992000},"page":"173-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication"],"prefix":"10.1016","volume":"338","author":[{"given":"Shin-ichi","family":"Yokota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Yokosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Okabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Suzutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2005.04.028_bib1","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don't know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.virol.2005.04.028_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nri818","article-title":"Suppressors of cytokine signalling (SOCS) in the immune system","volume":"2","author":"Alexander","year":"2002","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.virol.2005.04.028_bib3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1096\/fj.02-0664fje","article-title":"IFN-\u03b1 antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3","volume":"17","author":"Bode","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.virol.2005.04.028_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V97.4.1056","article-title":"STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma","volume":"97","author":"Brender","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.virol.2005.04.028_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virol.2005.04.028_bib6","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/JVI.78.8.4185-4196.2004","article-title":"Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites","volume":"78","author":"Chee","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib7","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1128\/JVI.77.12.7101-7105.2003","article-title":"Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects","volume":"77","author":"Chee","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00024382-200202000-00001","article-title":"Suppressors of cytokine signaling (SOCS): inhibitors of the JAK\/STAT pathway","volume":"17","author":"Cooney","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.virol.2005.04.028_bib9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.virol.2005.04.028_bib10","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1128\/JVI.72.8.6581-6591.1998","article-title":"The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms","volume":"72","author":"Everett","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib11","first-page":"150","article-title":"2\u20135A and virus infection","volume":"vol. 14","author":"Fujii","year":"1994"},{"key":"10.1016\/j.virol.2005.04.028_bib12","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","article-title":"Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures","volume":"81","author":"Goodbourn","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/107999099313929","article-title":"Augmentation of verotoxin-induced cytotoxicity\/apoptosis by interferon is repressed in cells persistently infected with mumps virus","volume":"19","author":"Hariya","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.virol.2005.04.028_bib14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1073\/pnas.94.3.843","volume":"94","author":"He","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2005.04.028_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0006-291X(02)03071-1","article-title":"Cloning and characterization of a functional promoter of the human SOCS-3 gene","volume":"301","author":"He","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2005.04.028_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1634\/stemcells.19-5-378","article-title":"SOCS proteins: negative regulators of cytokine signaling","volume":"19","author":"Krebs","year":"2001","journal-title":"Stem Cells"},{"key":"10.1016\/j.virol.2005.04.028_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","article-title":"Jaks and STATs: biological implications","volume":"16","author":"Leonard","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virol.2005.04.028_bib18","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1128\/JVI.78.4.1675-1684.2004","article-title":"The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes","volume":"78","author":"Lin","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib19","doi-asserted-by":"crossref","first-page":"25014","DOI":"10.1074\/jbc.M211867200","article-title":"Desensitization of signaling by oncostatin M in human vascular cells involves cytoplasmic Tyr residue 759 in gp130 but is not mediated by either Src homology 2 domain-containing tyrosine phosphatase 2 or suppressor of cytokine signaling 3","volume":"278","author":"Mahboubi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2005.04.028_bib20","doi-asserted-by":"crossref","first-page":"27028","DOI":"10.1074\/jbc.274.38.27028","article-title":"Targeting janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis","volume":"274","author":"Malaviya","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2005.04.028_bib21","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1128\/JVI.78.16.8411-8420.2004","article-title":"Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production","volume":"78","author":"Melroe","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib22","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1128\/JVI.78.11.5883-5890.2004","article-title":"Suppression of proinflammatory cytokine expression by herpes simplex virus type 1","volume":"78","author":"Mogensen","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib23","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1128\/JVI.78.18.10193-10196.2004","article-title":"Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon requires both the Us11 and \u03b3134.5 gene products","volume":"78","author":"Mulvey","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib24","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1073\/pnas.100135197","article-title":"Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130","volume":"97","author":"Nicholson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2005.04.028_bib25","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0092-8674(02)00701-8","article-title":"Cytokitone signaling in 2002: new surprises in the Jak\/Stat pathway","volume":"109","author":"O'Shea","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.virol.2005.04.028_bib26","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/blood-2002-01-0073","article-title":"Constitutive expression of SOCS3 confers resistance to IFN-\u03b1 in chronic myelogenous leukemia cells","volume":"100","author":"Sakai","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.virol.2005.04.028_bib27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virol.2005.04.028_bib28","doi-asserted-by":"crossref","first-page":"12848","DOI":"10.1074\/jbc.275.17.12848","article-title":"SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130","volume":"275","author":"Schmitz","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2005.04.028_bib29","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm896","article-title":"SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses","volume":"9","author":"Seki","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2005.04.028_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-3527(08)60083-4","article-title":"Interferon-induced antiviral actions and their regulation","volume":"42","author":"Sen","year":"1993","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2005.04.028_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/107999001300177466","article-title":"Participation of type I interferon in the decreased virulence of the UL13 gene-deleted mutant of herpes simplex virus type 1","volume":"21","author":"Shibaki","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.virol.2005.04.028_bib32","doi-asserted-by":"crossref","first-page":"35056","DOI":"10.1074\/jbc.273.52.35056","volume":"273","author":"Song","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2005.04.028_bib33","first-page":"1569","article-title":"Structure-based design of specific inhibitors of janus kinase 3 as apoptosis-inducing antileukemic agents","volume":"5","author":"Sudbeck","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virol.2005.04.028_bib34","first-page":"1763","article-title":"The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection","volume":"81","author":"Suzutani","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbapap.2003.11.013","article-title":"Tyrosine kinase inhibitors: a new approach for asthma","volume":"1697","author":"Wong","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.virol.2005.04.028_bib36","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/emboj\/18.5.1309","article-title":"The JAK-binding protein JAB inhibits janus tyrosine kinase activity through binding in the activation loop","volume":"18","author":"Yasukawa","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2005.04.028_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.immunol.18.1.143","article-title":"Negative regulation of cytokine signaling pathways","volume":"18","author":"Yasukawa","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virol.2005.04.028_bib38","doi-asserted-by":"crossref","first-page":"37070","DOI":"10.1074\/jbc.274.52.37070","article-title":"Cytosolic chaperonin is up-regulated during cell growth. Preferential expression and binding to tubulin at G1\/S transition through early S phase","volume":"274","author":"Yokota","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2005.04.028_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/viro.2001.0941","article-title":"Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage","volume":"286","author":"Yokota","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.04.028_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0042-6822(02)00026-0","article-title":"Measles virus suppresses interferon-\u03b1 signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-\u03b1 receptor complex","volume":"306","author":"Yokota","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.04.028_bib41","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1128\/JVI.78.9.4591-4598.2004","article-title":"Growth arrest of epithelial cells during measles virus infection is caused by upregulation of interferon regulatory factor 1","volume":"78","author":"Yokota","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.04.028_bib42","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1128\/JVI.78.12.6282-6286.2004","article-title":"Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway","volume":"78","author":"Yokota","year":"2004","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220500262X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220500262X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:36:20Z","timestamp":1758584180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268220500262X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S004268220500262X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.04.028","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}